ALIMTA

Manufacturer:

Eli Lilly and Company

Name:

ALIMTA

HCPCS Code Descriptor:

Injection, pemetrexed, not otherwise specified, 10 mg

Category:

J Code

HCPCS:

J9305

NDC(s):

71288-0167-50, 71288-0148-51, 71288-0166-10, 71288-0147-50, 70860-0203-50, 70860-0202-10, 70710-1674-01, 70710-1655-01, 70710-1654-01, 68001-0543-41, 68001-0544-41, 68001-0539-41, 68001-0538-41, 68001-0536-41, 68001-0535-41, 63323-0621-00, 63323-0622-00, 63323-0450-50, 63323-0134-10, 60505-6067-00, 60505-6068-00, 60505-6066-00, 60505-6065-00, 55150-0383-01, 55150-0381-01, 55150-0382-01, 50742-0341-01, 50742-0340-01, 43598-0370-74, 43598-0387-11, 43598-0386-62, 16729-0244-38, 16729-0230-11, 16729-0229-03, 00338-0720-01, 00338-0722-01, 00002-7640-01, 00002-7623-01

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

ALIMTA is an Oncology drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The J Code: J9305 is aligned to the drug ALIMTA.